Drug:
Reaction: MATERNAL EXPOSURE DURING PREGNANCY
20250101 - 20251231
No. 201 - 300
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
201 | 25115905 |
CO |
2 | |
Gestational diabetes, Caesarean section, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROXYCHLOROQUINE, INSULIN GLULISINE, HYDROXYCHLOROQUINE, SULFASALAZINE, FOLIC ACID, |
||||
202 | 25115976 |
US |
39 | 2 |
Maternal exposure during pregnancy, |
||||
OXYCODONE, FENTANYL, FENTANYL, FENTANYL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SEVOFLURANE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PROPOFOL, ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, NEOSTIGMINE, ATROPINE SULFATE, ATROPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, NALOXONE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, |
||||
203 | 25115999 |
US |
18 | 2 |
Maternal exposure during pregnancy, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
204 | 25116023 |
US |
4 | 2 |
Therapy partial responder, Maternal exposure during pregnancy, Off label use, |
||||
COLCHICINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, INFLIXIMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
205 | 25116028 |
US |
4 | 2 |
Therapy partial responder, Maternal exposure during pregnancy, Off label use, |
||||
AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, COLCHICINE, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, |
||||
206 | 25116072 |
GB |
2 | |
Maternal exposure during pregnancy, Abortion spontaneous, |
||||
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE, |
||||
207 | 25116365 |
ES |
5 | 2 |
Anorectal malformation, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CLOBAZAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FOLIC ACID, |
||||
208 | 25116397 |
IN |
2 | |
Premature baby, Low birth weight baby, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LABETALOL, |
||||
209 | 25116410 |
JO |
35 | 2 |
Foetal heart rate abnormal, Maternal exposure during pregnancy, |
||||
INTERFERON BETA-1A, |
||||
210 | 25116441 |
CA |
29 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, VALPROATE SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, FOLIC ACID, VALPROIC ACID, |
||||
211 | 25116980 |
US |
33 | 2 |
Abortion spontaneous, Dermatitis atopic, Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
212 | 25117075 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
213 | 25117080 |
FR |
2 | |
Maternal exposure during pregnancy, B-cell aplasia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, RITUXIMAB, VINCRISTINE SULFATE, PREDNISOLONE ACETATE, |
||||
214 | 25117134 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
UPADACITINIB, |
||||
215 | 25117518 |
CN |
39 | 2 |
Caesarean section, Maternal exposure during pregnancy, Off label use, Maternal exposure during breast feeding, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
216 | 25117545 |
CA |
44 | 2 |
Weight decreased, Weight fluctuation, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, Maternal exposure during pregnancy, Exposure during pregnancy, Colitis ulcerative, Confusional state, Contusion, Crohn^s disease, Delirium, Depression, Diarrhoea, Discomfort, Dry mouth, Joint swelling, Laboratory test abnormal, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, MAGNESIUM, SECUKINUMAB, SECUKINUMAB, PREGABALIN, MORPHINE, ALBUTEROL SULFATE, ALBUTEROL, ERGOCALCIFEROL, LORAZEPAM, RAMIPRIL, LANSOPRAZOLE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALBUTEROL SULFATE, CALCIUM, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, VITAMIN C, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CAFFEINE CITRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERYTHROMYCIN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LISINOPRIL, MELOXICAM, MESALAMINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, LISINOPRIL, |
||||
217 | 25117678 |
PL |
22 | 2 |
Haemorrhage in pregnancy, Uterine contractions during pregnancy, Premature rupture of membranes, Caesarean section, Exposure during pregnancy, Maternal exposure during pregnancy, |
||||
ALLOPURINOL, SERTRALINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, VORICONAZOLE, AMPHOTERICIN B, ITRACONAZOLE, TRIMETHOPRIM, HYDROXYZINE, |
||||
218 | 25117961 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
ASCIMINIB, |
||||
219 | 25118170 |
KZ |
2 | |
Loss of consciousness, Malaise, Serum ferritin increased, Maternal exposure during pregnancy, |
||||
220 | 25118353 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
221 | 25118886 |
US |
37 | 2 |
Rebound eczema, Dry skin, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
222 | 25118905 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
223 | 25118926 |
US |
41 | 2 |
Maternal exposure during pregnancy, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
224 | 25118928 |
SE |
33 | 2 |
Abortion missed, Maternal exposure during pregnancy, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, |
||||
225 | 25119019 |
US |
2 | |
Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, TRASTUZUMAB, PERTUZUMAB, |
||||
226 | 25119549 |
US |
2 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Therapeutic product effect decreased, |
||||
OXYTOCIN, |
||||
227 | 25119586 |
US |
2 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Therapeutic product effect decreased, |
||||
OXYTOCIN, |
||||
228 | 25119702 |
US |
35 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
229 | 25119707 |
US |
2 | |
Postpartum haemorrhage, Maternal exposure during pregnancy, Therapeutic product effect decreased, |
||||
OXYTOCIN, |
||||
230 | 25119809 |
FR |
||
Drug abuse, Premature separation of placenta, Toxicity to various agents, Maternal exposure during pregnancy, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ALPRAZOLAM, MIRTAZAPINE, ZOLPIDEM TARTRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
231 | 25120058 |
US |
31 | 2 |
Psoriatic arthropathy, Maternal exposure before pregnancy, Maternal exposure during pregnancy, Drug ineffective, Off label use, |
||||
CERTOLIZUMAB PEGOL, |
||||
232 | 25120129 |
FR |
30 | 2 |
Toxicity to various agents, Premature separation of placenta, Drug abuse, Maternal exposure during pregnancy, |
||||
ALPRAZOLAM, MIRTAZAPINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ZOLPIDEM TARTRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
233 | 25120293 |
FR |
32 | 2 |
Partial seizures, Drug dependence, Drug dependence, antepartum, Drug withdrawal syndrome neonatal, Maternal exposure during pregnancy, |
||||
METHADONE HYDROCHLORIDE, METHADONE, |
||||
234 | 25120592 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Deep vein thrombosis postoperative, Gait inability, Hypersensitivity, Hypertension, Hypertransaminasaemia, Infusion related reaction, Injury, Joint swelling, Leukopenia, Liver injury, Musculoskeletal stiffness, Oedema, Pain, Pemphigus, Pericarditis, Peripheral swelling, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, PREGABALIN, APREMILAST, INFLIXIMAB, INFLIXIMAB, VITAMIN C, CELECOXIB, CELECOXIB, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, PREGABALIN, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CAFFEINE, CALCIUM, CYANOCOBALAMIN, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, LORAZEPAM, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PIROXICAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, ERGOCALCIFEROL, |
||||
235 | 25120670 |
GB |
35 | 2 |
Ectopic pregnancy, Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
236 | 25120737 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
237 | 25120908 |
CA |
38 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
ATOGEPANT, |
||||
238 | 25109854 |
AU |
2 | |
Abortion spontaneous, Maternal exposure during pregnancy, Alopecia, Fatigue, Diarrhoea, Nausea, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SIROLIMUS, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
239 | 25109914 |
GB |
46 | 2 |
Unexpected vaginal bleeding on hormonal IUD, Maternal exposure during pregnancy, |
||||
LEVONORGESTREL, |
||||
240 | 25110216 |
US |
1 | |
Neonatal respiratory distress, Meconium aspiration syndrome, Cyanosis neonatal, Premature baby, Hypoglycaemia, Maternal exposure during pregnancy, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUPROPION HYDROCHLORIDE, BUPROPION, PROGESTERONE, |
||||
241 | 25110239 |
CO |
27 | 2 |
Seizure, Lactation insufficiency, Maternal exposure during pregnancy, Maternal exposure during breast feeding, Product prescribing issue, Product distribution issue, Treatment noncompliance, Therapy cessation, |
||||
BRIVARACETAM, BRIVARACETAM, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, OXCARBAZEPINE, OXCARBAZEPINE, HYDROXYZINE, |
||||
242 | 25110456 |
FR |
30 | |
Foetal growth restriction, Oligohydramnios, Maternal exposure during pregnancy, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
243 | 25110579 |
AU |
||
Premature delivery, Maternal exposure during pregnancy, |
||||
RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VINCRISTINE SULFATE, |
||||
244 | 25110646 |
FR |
||
Premature separation of placenta, Toxicity to various agents, Drug abuse, Maternal exposure during pregnancy, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, MIRTAZAPINE, ZOLPIDEM TARTRATE, ALPRAZOLAM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
245 | 25110668 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Hypersensitivity, Infusion related reaction, Swelling, Gait inability, Pericarditis, Deep vein thrombosis postoperative, Peripheral swelling, Injury, Musculoskeletal stiffness, Maternal exposure during pregnancy, Rheumatic fever, Synovitis, Leukopenia, Pain, Psoriatic arthropathy, Oedema, Hypertransaminasaemia, Swollen joint count increased, Rash, Hypertension, Liver injury, Rheumatoid factor positive, Joint swelling, Pemphigus, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LISINOPRIL, RITUXIMAB, RITUXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, MAGNESIUM, ADALIMUMAB, CALCIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CORTISONE ACETATE, CALCIUM CARBONATE, APREMILAST, MELOXICAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, PREDNISONE, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISOLONE SODIUM PHOSPHATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, VITAMIN C, LORAZEPAM, CYANOCOBALAMIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, QUETIAPINE FUMARATE, QUETIAPINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, GOLIMUMAB, SARILUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, PREGABALIN, RAMIPRIL, LORAZEPAM, TOCILIZUMAB, TOCILIZUMAB, RISEDRONATE SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, LANSOPRAZOLE, INFLIXIMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PIROXICAM, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, HYDROCORTISONE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, SECUKINUMAB, CAFFEINE, SULFASALAZINE, APREMILAST, FISH OIL, |
||||
246 | 25110780 |
CA |
59 | 2 |
Liver injury, Oedema peripheral, Blood cholesterol increased, Helicobacter infection, Glossodynia, Duodenal ulcer perforation, Asthma, Pericarditis, Musculoskeletal stiffness, Hypercholesterolaemia, Therapeutic product effect incomplete, Fibromyalgia, Adverse event, Malaise, Infusion related reaction, General physical health deterioration, Decreased appetite, Pain, Drug intolerance, Anti-cyclic citrullinated peptide antibody, Contraindicated product administered, Discomfort, Pain in extremity, Fatigue, Rheumatic fever, Diarrhoea, Red blood cell sedimentation rate increased, Arthropathy, Rheumatoid factor positive, Headache, Rheumatoid arthritis, Hypertension, Product use in unapproved indication, Abdominal discomfort, Lupus vulgaris, Rash, Off label use, Joint swelling, Product use issue, Drug ineffective, Arthralgia, Mobility decreased, Anti-cyclic citrullinated peptide antibody positive, Adverse drug reaction, Hand deformity, Visual impairment, Hepatic enzyme increased, Hypersensitivity, Retinitis, Injury, Wound, Pemphigus, Therapeutic product effect decreased, Maternal exposure during pregnancy, Type 2 diabetes mellitus, Blister, Exposure during pregnancy, Alopecia, Anxiety, Hypoaesthesia, Intentional product use issue, Psoriatic arthropathy, Systemic lupus erythematosus, Treatment failure, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ETANERCEPT, ETANERCEPT, ETANERCEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LISINOPRIL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, SARILUMAB, CAFFEINE CITRATE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SULFASALAZINE, PREDNISONE, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM GLUCONATE, CALCIUM GLUCONATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, |
||||
247 | 25110829 |
CG |
||
Caesarean section, Maternal exposure during pregnancy, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, GENTAMICIN, GENTAMICIN SULFATE, ALBENDAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
248 | 25110878 |
US |
37 | 2 |
Drug ineffective, Maternal exposure during pregnancy, |
||||
LABETALOL, LABETALOL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, NIFEDIPINE, |
||||
249 | 25110893 |
US |
29 | 2 |
Premature delivery, Maternal exposure during pregnancy, Maternal exposure during breast feeding, |
||||
LABETALOL, LABETALOL, NIFEDIPINE, NIFEDIPINE, DARBEPOETIN ALFA, DARBEPOETIN ALFA, HYDROXYCHLOROQUINE SULFATE, |
||||
250 | 25110910 |
US |
27 | 2 |
Off label use, Maternal exposure during pregnancy, |
||||
METOPROLOL TARTRATE, METOPROLOL, LABETALOL, CARVEDILOL, HYDRALAZINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
251 | 25110912 |
US |
31 | 2 |
Maternal exposure during pregnancy, |
||||
LABETALOL, NIFEDIPINE, SEMAGLUTIDE, |
||||
252 | 25110913 |
US |
32 | 2 |
Dizziness, Maternal exposure during pregnancy, |
||||
LABETALOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
253 | 25110978 |
NL |
2 | |
Abortion spontaneous, Paternal exposure during pregnancy, Maternal exposure during pregnancy, |
||||
254 | 25110982 |
US |
33 | 2 |
Maternal exposure during pregnancy, |
||||
LABETALOL, LABETALOL, PROPYLTHIOURACIL, |
||||
255 | 25111279 |
US |
16 | 2 |
Premature delivery, Maternal exposure during pregnancy, |
||||
LABETALOL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, NIFEDIPINE, OXYTOCIN, |
||||
256 | 25111328 |
US |
37 | 2 |
Drug-induced liver injury, Maternal exposure during pregnancy, Off label use, |
||||
LABETALOL, ACETYLCYSTEINE, |
||||
257 | 25111798 |
NL |
2 | |
Drug ineffective, Maternal exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
258 | 25111828 |
CA |
32 | 2 |
Premature delivery, Product use in unapproved indication, Maternal exposure during pregnancy, |
||||
DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, DIAZEPAM, BACLOFEN, BACLOFEN, BACLOFEN, BACLOFEN, SERTRALINE HYDROCHLORIDE, METHAMPHETAMINE HYDROCHLORIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
259 | 25111998 |
ES |
39 | 2 |
Abortion missed, Maternal exposure during pregnancy, |
||||
260 | 25112137 |
CA |
44 | 2 |
Pulmonary fibrosis, Pruritus, Wound infection, Rectal haemorrhage, Weight fluctuation, Retinitis, Pericarditis, Swollen joint count increased, Vomiting, Swollen joint count, Urticaria, Wheezing, Road traffic accident, Pneumonia, Rheumatoid factor positive, Injury, Swelling, Pyrexia, Sleep disorder due to a general medical condition, White blood cell count increased, Maternal exposure during pregnancy, Type 2 diabetes mellitus, Rheumatic fever, Peripheral swelling, Synovitis, Sinusitis, Weight decreased, Peripheral venous disease, Rheumatoid arthritis, Visual impairment, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Weight increased, Rash, Wound, Pemphigus, Systemic lupus erythematosus, Sciatica, Psoriatic arthropathy, Porphyria acute, |
||||
CALCIUM CARBONATE, ALBUTEROL SULFATE, ALBUTEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, MELOXICAM, LANSOPRAZOLE, APREMILAST, APREMILAST, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, FLUOROMETHOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, PREDNISONE, PREDNISONE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, RAMIPRIL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CAFFEINE, LANSOPRAZOLE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, MORPHINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, LORAZEPAM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, SECUKINUMAB, SECUKINUMAB, LORAZEPAM, ERYTHROMYCIN, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, USTEKINUMAB, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, SECUKINUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, HYALURONIDASE, LISINOPRIL, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MAGNESIUM, TOFACITINIB, APREPITANT, FOSAPREPITANT DIMEGLUMINE, PREGABALIN, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MESALAMINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, TOFACITINIB, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LISINOPRIL, RITUXIMAB, RITUXIMAB, |
||||
261 | 25112220 |
US |
23 | 2 |
Maternal exposure during pregnancy, Maternal exposure before pregnancy, Off label use, |
||||
BRIVARACETAM, BRIVARACETAM, CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, CANNABIDIOL, FOLIC ACID, |
||||
262 | 25112382 |
US |
2 | |
Maternal exposure during pregnancy, Maternal exposure before pregnancy, |
||||
BRIVARACETAM, |
||||
263 | 25112417 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
BRIVARACETAM, |
||||
264 | 25112952 |
US |
32 | 2 |
Abnormal cord insertion, Maternal exposure during pregnancy, |
||||
ONABOTULINUMTOXINA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, FERROUS SULFATE, |
||||
265 | 25113283 |
US |
37 | 2 |
Maternal exposure during pregnancy, Maternal exposure before pregnancy, |
||||
BIMEKIZUMAB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE GEL USP, 1%, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SECUKINUMAB, |
||||
266 | 25113441 |
CO |
2 | |
Placental disorder, Diarrhoea, Vomiting, Maternal exposure during pregnancy, Off label use, |
||||
CERTOLIZUMAB PEGOL, SERTRALINE, FERROUS SULFATE, FOLIC ACID, |
||||
267 | 25113494 |
EG |
33 | 2 |
Haemorrhage in pregnancy, Maternal exposure during pregnancy, |
||||
NATALIZUMAB, NATALIZUMAB, FOLIC ACID, |
||||
268 | 25113501 |
IT |
31 | 2 |
HIV viraemia, Maternal exposure during pregnancy, Product administration error, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
269 | 25113845 |
IN |
3 | 2 |
Superimposed pre-eclampsia, Gingivitis, Maternal exposure during pregnancy, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ATENOLOL, AZATHIOPRINE, AZATHIOPRINE, AMLODIPINE, AMLODIPINE, IRON, CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LABETALOL, LABETALOL, LABETALOL, |
||||
270 | 25113911 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
OFATUMUMAB, |
||||
271 | 25113922 |
FR |
30 | 2 |
Premature separation of placenta, Toxicity to various agents, Drug abuse, Maternal exposure during pregnancy, |
||||
MIRTAZAPINE, ALPRAZOLAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ZOLPIDEM TARTRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
272 | 25113980 |
IN |
26 | 2 |
Autism spectrum disorder, Maternal exposure during pregnancy, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, CLOBAZAM, |
||||
273 | 25114183 |
US |
42 | 2 |
Gestational diabetes, Live birth, Maternal exposure during pregnancy, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ONABOTULINUMTOXINA, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
274 | 25114263 |
US |
2 | |
Nausea, Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
275 | 25114354 |
US |
2 | |
Maternal exposure during pregnancy, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
276 | 25114501 |
US |
37 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
277 | 25114569 |
US |
35 | 2 |
Extrasystoles, Maternal exposure during pregnancy, |
||||
DOBUTAMINE HYDROCHLORIDE, ISOSORBIDE DINITRATE, METOPROLOL TARTRATE, METOPROLOL, HYDRALAZINE HYDROCHLORIDE, |
||||
278 | 25114669 |
CA |
32 | 2 |
Seizure, Maternal exposure during pregnancy, |
||||
LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, VALPROATE SODIUM, FOLIC ACID, |
||||
279 | 25114992 |
RU |
19 | 2 |
Tachypnoea, Fear, Back pain, Chills, Tachycardia, Maternal exposure during pregnancy, |
||||
280 | 25115040 |
DE |
35 | 2 |
Premature delivery, Maternal exposure during pregnancy, |
||||
SECUKINUMAB, |
||||
281 | 25115089 |
US |
38 | 2 |
Maternal exposure during pregnancy, |
||||
UPADACITINIB, |
||||
282 | 25115102 |
FR |
||
Trisomy 21, Maternal exposure during pregnancy, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
283 | 25109264 |
US |
16 | 2 |
Abortion, Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
284 | 25109420 |
GB |
2 | |
Urinary tract infection, Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, FOLIC ACID, |
||||
285 | 25107871 |
US |
27 | 2 |
Abdominal discomfort, Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
286 | 25107980 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
287 | 25108033 |
US |
27 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
288 | 25108338 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
ADALIMUMAB, |
||||
289 | 25108546 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
UPADACITINIB, |
||||
290 | 25108806 |
US |
32 | 2 |
Abnormal cord insertion, Maternal exposure during pregnancy, |
||||
ONABOTULINUMTOXINA, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, FERROUS SULFATE, |
||||
291 | 25108872 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
292 | 25108975 |
FR |
3 | 2 |
Foetal growth restriction, Maternal exposure during pregnancy, Foetal heart rate disorder, Hospitalisation, Neonatal gastrointestinal disorder, Neonatal hyperglycaemia, Neonatal respiratory depression, Premature baby, Transfusion, |
||||
FUROSEMIDE, PENICILLIN G BENZATHINE, BISOPROLOL FUMARATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ENOXAPARIN SODIUM, |
||||
293 | 25108976 |
FR |
0 | 2 |
Foetal growth restriction, Neonatal gastrointestinal disorder, Premature baby, Hospitalisation, Maternal exposure during pregnancy, Neonatal respiratory depression, |
||||
FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ENOXAPARIN SODIUM, BISOPROLOL FUMARATE, PENICILLIN G BENZATHINE, |
||||
294 | 25109007 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
UPADACITINIB, |
||||
295 | 25102794 |
31 | 2 | |
Oligohydramnios, Rash, Maternal exposure during pregnancy, |
||||
ERLOTINIB HYDROCHLORIDE, ERLOTINIB, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, |
||||
296 | 25102881 |
US |
25 | 2 |
Foetal malpresentation, Maternal exposure during pregnancy, Maternal exposure during delivery, Off label use, |
||||
LABETALOL, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, MAGNESIUM, OXYTOCIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
297 | 25103043 |
FR |
1 | |
Maternal exposure during pregnancy, Term birth, Normal newborn, |
||||
MONTELUKAST SODIUM, MONTELUKAST, DUPILUMAB, |
||||
298 | 25103156 |
US |
32 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DAPSONE GEL, 5%, DAPSONE, DASPONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
299 | 25103330 |
NO |
30 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
OSELTAMIVIR PHOSPHATE, |
||||
300 | 25103511 |
FR |
||
Caesarean section, Maternal exposure during pregnancy, |
||||
BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, FUROSEMIDE, RAMIPRIL, EPLERENONE, DAPAGLIFLOZIN, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28